A Toronto native, graduate of McMaster University, Harvard Medical School, and previous MIT researcher, Dr. Succi’s work is focused on device invention, intellectual property, operations, business-in-medicine, medical content production, and education. He holds multiple published or pending patents, several of which are licensed to public and private biotechnology companies. He is the founder of two medically-focused startups, and currently the CEO of one.
Dr. Succi has been named to the Forbes Magazine Top 30 Under 30 in Science and Healthcare List, won the MIT Data Prize, named one of the top Outstanding Young Entrepreneurs and Innovators by CEO World, and was awarded Governor General’s Medal of Canada. Dr. Succi is the only person to have won the Massachusetts Medical Society Information Technology Award twice throughout the award's 20 year history. He has received the Partners 2017, 2018, 2019, 2020 Innovation Award for his work in IP and devices.
Dr. Succi is the Founder and Executive Director of the Medically Engineered Solutions in Healthcare (MESH) Incubator at MGH, a first-in-kind division designed to harness ground-level clinical needs into patentable and licensable intellectual property. MESH collaborates with both internal Harvard labs as well as external industry, MIT, Harvard Business School and many others. MESH holds multiple pending or published patents and is the creator of the first integrated innovation curriculum in a medical training program (www.meshincubator.com).
Dr. Succi is the founder and Chief Editor of 2 Minute Medicine®, an award-winning medical publishing company and peer-reviewed medical news and content licensor. The organization licenses its original medical content and news to industries around the globe, including the biotech, pharma, publishing, imaging, and education industries. He leads a staff of over 70 physicians and medical professionals in this role (www.2minutemedicine.com).
As a writer, Dr. Succi has personally written/edited and licensed over 500 medical reports reviewing practice-changing literature to the biotech, pharma, publishing, imaging, and education industries, including co-authoring two textbooks.